The growing of hemp for any purpose, including the extraction of CBD, is prohibited in Taiwan by the Narcotics Hazard Prevention Act. No change appears to be imminent in the regulatory environment for hemp in Taiwan. Although the public has called on the authorities to legalise medical cannabis, it is unlikely to happen in the near future.
This report provides a detailed overview of the current regulatory framework in place for CBD, hemp and cannabis in Taiwan, covering all policy areas from cultivation and processing to extracts, finished products and import/export.
This report provides a detailed overview of the current regulatory framework in place for CBD, hemp and cannabis in Taiwan, covering all policy areas from cultivation and processing to extracts, finished products and import/export.
Table of Contents
1 Executive summary2 Outlook
3 Hemp plant
4 Extracts as finished products
5 Finished products containing CBD and extracts
6 Import and export
7 Medical cannabis
8 Recreational cannabis
9 Relevant laws
10 Relevant bodies
Methodology
General Methodology/Sources
- Consumer and market participant (manufacturer/brand) surveys.
- Consolidation of publicly available information.
- Legal tracking through legal database checking and sourcing information from government regulators and other law-making bodies.
- Pricing and product information from online and offline retail data gathering, including local fieldwork teams.
- Findings from key industry events and interviews with leading market players and opinion leaders.
- Partnerships with leading research agencies.
- Quantitative and qualitative research and client collaborations.
- Cross-referenced data between markets.
- Tamarind Media proprietary market model.
Please note that each report has its own methodology, so you should always refer to the methodology applied in the report you purchase.
LOADING...
